Table 2. Cross-correlation of mRNA expression and PET measures of specific binding.
| Receptor system |
mRNA expression vs. PET-specific binding cross-correlation (ρ2) |
|||
|---|---|---|---|---|
| min | max | Mean | s.d. | |
| Delta-opioid receptor mRNA and [11C]DPN VT | ||||
| Probe 1 | 0.000 | 0.116 | 0.028 | 0.034 |
| Probe 2 | 0.000 | 0.339 | 0.053 | 0.082 |
| Kappa-opioid receptor mRNA and [11C]DPN VT | ||||
| Probe 1 | 0.102 | 0.626 | 0.355 | 0.122 |
| Probe 2 | 0.302 | 0.783 | 0.513 | 0.121 |
| Probe 3 | 0.000 | 0.379 | 0.108 | 0.110 |
| Mu-opioid receptor mRNA and [11C]DPN VT | ||||
| Probe 1 | 0.005 | 0.339 | 0.090 | 0.086 |
| Probe 2 | 0.010 | 0.245 | 0.110 | 0.058 |
| Probe 3 | 0.000 | 0.223 | 0.054 | 0.064 |
| 5-HT1A receptor mRNA and [11C]WAY VT | ||||
| Probe 1 | 0.679 | 0.991 | 0.882 | 0.055 |
| Probe 2 | 0.158 | 0.784 | 0.565 | 0.197 |
| Probe 3 | 0.658 | 0.965 | 0.858 | 0.064 |
| 5-HT1A receptor mRNA and [11C]CUMI BP | ||||
| Probe 1 | 0.236 | 0.623 | 0.446 | 0.101 |
| Probe 2 | 0.096 | 0.746 | 0.392 | 0.157 |
| Probe 3 | 0.227 | 0.595 | 0.433 | 0.092 |
PET, positron emission tomography; [11C]DPN, [11C]diprenorphine; BP, binding potential; VT, total distribution volume.